Daiwa Securities Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Daiwa Securities Group’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-671	Closed	-$35K	–	1320
2020 Q3	$35K	Buy	671 +18	+3%	+$745	﹤0.01%	959
2020 Q2	$18K	Hold	653	–	–	﹤0.01%	1030
2020 Q1	$18K	Buy	653 +95	+17%	+$2.65K	﹤0.01%	1016
2019 Q4	$11K	Sell	558 -68	-11%	-$1.09K	﹤0.01%	1060
2019 Q3	$8K	Hold	626	–	–	﹤0.01%	1049
2019 Q2	$8K	Hold	626	–	–	﹤0.01%	1072
2019 Q1	$9K	Buy	626 +204	+48%	+$2.61K	﹤0.01%	1043
2018 Q4	$5K	Hold	422	–	–	﹤0.01%	1068
2018 Q3	$11K	Hold	422	–	–	﹤0.01%	1034
2018 Q2	$9K	Hold	422	–	–	﹤0.01%	1063
2018 Q1	$8K	Buy	+422	New	+$7.04K	﹤0.01%	1051

Daiwa Securities Group's MNTA Position: Q4 2020 in Review

Daiwa Securities Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 671 shares — an estimated $35K sold.

Daiwa Securities Group first reported a position in MNTA in Q1 2018 and held it in 11 quarters. The position peaked at $35K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Daiwa Securities Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Daiwa Securities Group sold 671 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $35K.
Daiwa Securities Group first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2018 and held it in 11 quarters.
Daiwa Securities Group's Momenta Pharmaceuticals, Inc. position peaked at $35K in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.